Please assess the completion status of the following clinical trial:

Trial Title: MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with cardiac resynchronization therapy with a defibrillator (CRT-D) or cardiac resynchronization therapy pacemakers (CRT-P) system~* New York Heart Association (NYHA) III~* Ejection fraction (EF) below 35%~* Optimised medical therapy~* QRS-complex above 120 ms~Exclusion Criteria:~* Patients with CRT-P and atrial fibrillation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- QRS 120-150 ms (Type: None): Subjects with a QRS width between 120-150 ms
- QRS >150 ms (Type: None): Subjects with a QRS width \>150 ms

Based on this trial design, predict the completion outcome and termination type (if applicable).